Acute treatment response and its predictors in patients with first-episode psychosis in Iran

Australasian Psychiatry

Volumn 16, Issue 2, 2008, Pages 125-129

  Tabatabaee, Maryam ^a   Sharifi, Vandad ^a   Alaghband Rad, Javad ^a   Amini, Homayoun ^a   Boroumand, Mehran ^a   Omid, Abbas ^b   Seddigh, Arshia ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

First episode psychosis; Iran; Treatment response

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; LITHIUM SALT; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL PROTOCOL; DEMOGRAPHY; DEVELOPING COUNTRY; DRUG RESPONSE; FAMILY HISTORY; FEMALE; FIRST EPISODE PSYCHOSIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IRAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; NEGATIVE SYNDROME; POSITIVE SYNDROME; PREDICTION; PRESCRIPTION; PSYCHOSIS;

ACUTE DISEASE; ADULT; BIPOLAR DISORDER; DEMOGRAPHY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IRAN; MALE; MENTAL HEALTH SERVICES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 40949150802     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560701636963     Document Type: Article

References (24)

1. Crespo-Facorro, B., Pelayo-Teran, JM and Perez-Iglesias, R. (2007) Predictors of acute treatment response in patients with a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables. Journal of Psychiatric Research, 41, pp. 659-666.
2. Emsley, R., Oosthuizen, PP, Kidd, M., Koen, L., Niehaus, DJ and Turner, HJ. (2006) Remission in first-episode psychosis: Predictor variables and symptom improvement patterns. Journal of Clinical Psychiatry, 67, pp. 1707-1712.
3. Craig, TJ, Siegel, C., Hopper, K., Lin, S. and Sartorius, N. (1997) Outcome in schizophrenia and related disorders compared between developing and developed countries. A recursive partitioning re-analysis of the WHO DOSMD data. British Journal of Psychiatry, 170, pp. 229-233.
4. Alaghband-Rad, J., Boroumand, M. and Amini, H. (2006) Non-affective acute remitting psychosis: A preliminary report from Iran. Acta Psychiatrica Scandinavica, 113, pp. 96-101.
5. Sartorius, N., Jablensky, A. and Shapiro, R. (1977) Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychological Medicine, 7, pp. 529-541.
6. Amini, H., Alaghband-Rad, J. and Omid, A. (2005) Diagnostic stability in patients with first-episode psychosis. Australasian Psychiatry, 13, pp. 388-392.
7. Jablensky, A., Sartorius, N. and Ernberg, G. (1992) Schizophrenia: manifestations, incidence and course in different culture. A World Health Organization ten-country study. Psychological Medicine Monograph, 20, pp. 1-97.
8. Woods, SW. (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry, 64, pp. 663-667.
9. Szekeres, G., Keri, S. and Juhasz, A. (2004) Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. American Journal of Medical Genetics B Neuropsychiatric Genetics, 124, pp. 1-5.
10. Goff, DC, Tsai, G. and Levitt, J. (1999) A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Archives of General Psychiatry, 56, pp. 21-27.
11. Norman, RM, Malla, AK, Cortese, L. and Diaz, F. (1996) A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophrenia Research, 19, pp. 73-85.
12. Robinson, DG, Woerner, MG, Delman, HM and Kane, JM. (2005) Pharmacological treatments for first-episode schizophrenia. Schizophrenia Bulletin, 31, pp. 705-722.
13. Hopper, K. and Wanderling, J. (2000) Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophrenia Bulletin, 26, pp. 835-846.
14. Penn, DL, Waldheter, EJ, Perkins, DO, Mueser, KT and Lieberman, JA. (2005) Psychosocial treatment for first-episode psychosis: A research update. American Journal of Psychiatry, 162, pp. 2220-2232.
15. Lehtinen, V., Aaltonen, J., Koffert, T., Räkköläinen, V. and Syvälahti, E. (2000) Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?. European Psychiatry, 15, pp. 312-320.
16. Conus, P., Cotton, S., Abdel-Baki, A., Lambert, M., Berk, M. and McGorry, PD. (2006) Symptomatic and functional outcome 12 months after a first episode of psychotic mania: Barriers to recovery in a catchment area sample. Bipolar Disorders, 8, pp. 221-231.
17. Robinson, DG, Woerner, MG, McMeniman, M., Mendelowitz, A. and Bilder, RM. (2004) Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 161, pp. 473-479.
18. Hatta, K., Nakamura, H. and Matsuzaki, I. (2003) Acute-phase treatment in general hospitals: Clinical psychopharmacologic evaluation in first-episode schizophrenia patients. General Hospital Psychiatry, 25, pp. 39-45.
19. Perkins, D., Lieberman, J. and Gu, H. (2004) Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. British Journal of Psychiatry, 185, pp. 18-24.
20. Rabinowitz, J., Harvey, PD, Eerdekens, M. and Davidson, M. (2006) Premorbid functioning and treatment response in recent-onset schizophrenia. British Journal of Psychiatry, 189, pp. 31-35.
21. Robinson, DG, Woerner, MG and Alvir, JM (1999) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 156, pp. 544-549.
22. Mojtabai, R., Susser, ES and Bromet, EJ. (2003) Clinical characteristics, 4-year course, and DSM-IV classification of patients with nonaffective acute remitting psychosis. American Journal of Psychiatry, 160, pp. 2108-2115.
23. Susser, E., Varma, VK and Mattoo, SK (1998) Long-term course of acute brief psychosis in a developing country setting. British Journal of Psychiatry, 173, pp. 226-230.
24. Susser, E. and Wanderling, J. (1994) Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Archives of General Psychiatry, 51, pp. 294-301.